Quetiapine Fumarate

Product NDC: 46708-135
Requested package NDC: 46708-135-30
11-digit product format: 467080135
Labeler code: 46708
Product ID: 46708-135_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: quetiapine fumarate
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Alembic Pharmaceuticals Limited
Application: ANDA203390
Marketing category: ANDA
Marketing start: 2017-02-21
Substance: QUETIAPINE FUMARATE
Active strength: 50 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A203390-001	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28
A203390-002	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28
A203390-003	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28
A203390-004	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28
A203390-005	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28
A203390-006	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-005	QUETIAPINE FUMARATE	EQ 300MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203390-006	QUETIAPINE FUMARATE	EQ 400MG BASE	TABLET / ORAL	2014-10-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203390-001	QUETIAPINE FUMARATE	EQ 25MG BASE	TABLET / ORAL	2014-10-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203390-002	QUETIAPINE FUMARATE	EQ 50MG BASE	TABLET / ORAL	2014-10-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203390-003	QUETIAPINE FUMARATE	EQ 100MG BASE	TABLET / ORAL	2014-10-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203390-004	QUETIAPINE FUMARATE	EQ 200MG BASE	TABLET / ORAL	2014-10-28	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A203390-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203390-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203390-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203390-004	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203390-005	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203390-006	AB	1	`74a2ff9319b5…`
2020-11-12 02:37 UTC	2020-11	A203390-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203390-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203390-003	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203390-004	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203390-005	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203390-006	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203390-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203390-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203390-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203390-004	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203390-005	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203390-006	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203390-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203390-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203390-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203390-004	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203390-005	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203390-006	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203390-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203390-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203390-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203390-004	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203390-005	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203390-006	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Quetiapine Fumarate
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
QUETIAPINE FUMARATE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2S3PL1B6UJ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
312743	Internal RxNorm lookup
312744	Internal RxNorm lookup
312745	Internal RxNorm lookup
317174	Internal RxNorm lookup
616483	Internal RxNorm lookup
616487	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
5ef42f82-f087-0d2c-105f-f791ca69210e	Product name	8	20250729
21205abd-8c89-4943-9f85-908f3d4fc3bb	Product name	5	20230501

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
46708-135-10	2023-02-01	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-30	2023-02-01	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-31	2023-02-01	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-91	2023-02-01	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-10	2023-01-30	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-30	2023-01-30	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-31	2023-01-30	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997
46708-135-91	2023-01-30	These highlights do not include all the information needed to use QUETIAPINE FUMARATE TABLETS safely and effectively. See full prescribing information for QUETIAPINE FUMARATE TABLETS. QUETIAPINE FUMARATE tablets, for oral use Initial U.S. Approval: 1997

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
46708-135-10	Quetiapine Fumarate	100 in 1 CARTON	TABLET, FILM COATED	100	7
46708-135-30	Quetiapine Fumarate	30 in 1 BOTTLE	TABLET, FILM COATED	30	7
46708-135-31	Quetiapine Fumarate	100 in 1 BOTTLE	TABLET, FILM COATED	100	7
46708-135-91	Quetiapine Fumarate	1000 in 1 BOTTLE	TABLET, FILM COATED	1000	7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
QUETIAPINE FUMARATE	ACTIVE INGREDIENT	2S3PL1B6UJ	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
QUETIAPINE	ACTIVE MOIETY	BGL0JSY5SI	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
46708-135	QUETIAPINE FUMARATE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]	7	Current NDC, Legacy NDC, 4 package rows	20230202_93ab6237-321e-4a2c-b0ca-3fc9acb31f9a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Quetiapine Fumarate	QUETIAPINE FUMARATE	Alembic Pharmaceuticals Limited	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	2023-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203390 application number: ANDA203390 ndc (package): 46708-135-30 ndc (product): 46708-135 ndc11 (package): 46708013530

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2S3PL1B6UJ	QUETIAPINE FUMARATE	111974-72-2	QUETIAPINE FUMARATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312743	QUEtiapine fumarate 100 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
317174	QUEtiapine fumarate 200 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312744	QUEtiapine fumarate 25 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312745	QUEtiapine fumarate 300 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616483	QUEtiapine fumarate 400 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616487	QUEtiapine fumarate 50 MG Oral Tablet	PSN	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312743	quetiapine 100 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
317174	quetiapine 200 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312744	quetiapine 25 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312745	quetiapine 300 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616483	quetiapine 400 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616487	quetiapine 50 MG Oral Tablet	SCD	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312743	quetiapine (as quetiapine fumarate) 100 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
317174	quetiapine (as quetiapine fumarate) 200 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312744	quetiapine (as quetiapine fumarate) 25 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
312745	quetiapine (as quetiapine fumarate) 300 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616483	quetiapine (as quetiapine fumarate) 400 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7
616487	quetiapine (as quetiapine fumarate) 50 MG Oral Tablet	SY	93ab6237-321e-4a2c-b0ca-3fc9acb31f9a	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
46708-135-30	46708013530	30 TABLET, FILM COATED in 1 BOTTLE (46708-135-30)	2017-02-21	0000-00-00	No	No	Current